BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24547942)

  • 1. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis.
    Chang CH; Chen YC; Yu YH; Tao MH; Leung PS; Ansari AA; Gershwin ME; Chuang YH
    Clin Exp Immunol; 2014 Aug; 177(2):373-80. PubMed ID: 24547942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
    Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
    Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
    Wu SJ; Yang YH; Tsuneyama K; Leung PS; Illarionov P; Gershwin ME; Chuang YH
    Hepatology; 2011 Mar; 53(3):915-25. PubMed ID: 21374662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
    Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
    PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.
    Wakabayashi K; Lian ZX; Leung PS; Moritoki Y; Tsuneyama K; Kurth MJ; Lam KS; Yoshida K; Yang GX; Hibi T; Ansari AA; Ridgway WM; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2008 Aug; 48(2):531-40. PubMed ID: 18563844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization.
    Leung PS; Park O; Tsuneyama K; Kurth MJ; Lam KS; Ansari AA; Coppel RL; Gershwin ME
    J Immunol; 2007 Aug; 179(4):2651-7. PubMed ID: 17675529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.
    Naiyanetr P; Butler JD; Meng L; Pfeiff J; Kenny TP; Guggenheim KG; Reiger R; Lam K; Kurth MJ; Ansari AA; Coppel RL; López-Hoyos M; Gershwin ME; Leung PS
    J Autoimmun; 2011 Nov; 37(3):209-16. PubMed ID: 21763105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
    Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
    J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.
    Shimoda S; Tsuneyama K; Kikuchi K; Harada K; Nakanuma Y; Nakamura M; Ishibashi H; Hisamoto S; Niiro H; Leung PS; Ansari AA; Gershwin ME; Akashi K
    Clin Exp Immunol; 2012 Jun; 168(3):279-84. PubMed ID: 22519590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
    Wakabayashi K; Yoshida K; Leung PS; Moritoki Y; Yang GX; Tsuneyama K; Lian ZX; Hibi T; Ansari AA; Wicker LS; Ridgway WM; Coppel RL; Mackay IR; Gershwin ME
    Clin Exp Immunol; 2009 Mar; 155(3):577-86. PubMed ID: 19094117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice.
    Wang JJ; Yang GX; Zhang WC; Lu L; Tsuneyama K; Kronenberg M; Véla JL; Lopez-Hoyos M; He XS; Ridgway WM; Leung PS; Gershwin ME
    Clin Exp Immunol; 2014 Feb; 175(2):192-201. PubMed ID: 24128311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.
    Arsenijevic A; Milovanovic M; Milovanovic J; Stojanovic B; Zdravkovic N; Leung PS; Liu FT; Gershwin ME; Lukic ML
    Sci Rep; 2016 Mar; 6():23348. PubMed ID: 26996208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.
    Hsueh YH; Chen HW; Syu BJ; Lin CI; Leung PSC; Gershwin ME; Chuang YH
    J Autoimmun; 2018 Dec; 95():159-170. PubMed ID: 30274824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis.
    Chang CH; Chen YC; Zhang W; Leung PS; Gershwin ME; Chuang YH
    PLoS One; 2015; 10(3):e0121320. PubMed ID: 25807531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis.
    Dhirapong A; Yang GX; Nadler S; Zhang W; Tsuneyama K; Leung P; Knechtle S; Ansari AA; Coppel RL; Liu FT; He XS; Gershwin ME
    Hepatology; 2013 Feb; 57(2):708-15. PubMed ID: 22996325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
    Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis.
    Chen RC; Naiyanetr P; Shu SA; Wang J; Yang GX; Kenny TP; Guggenheim KC; Butler JD; Bowlus C; Tao MH; Kurth MJ; Ansari AA; Kaplan M; Coppel RL; Lleo A; Gershwin ME; Leung PS
    Hepatology; 2013 Apr; 57(4):1498-508. PubMed ID: 23184636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.
    Hsu W; Zhang W; Tsuneyama K; Moritoki Y; Ridgway WM; Ansari AA; Coppel RL; Lian ZX; Mackay I; Gershwin ME
    Hepatology; 2009 Jan; 49(1):133-40. PubMed ID: 19065673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.
    Yang JB; Wang YH; Yang W; Lu FT; Ma HD; Zhao ZB; Jia YJ; Tang W; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
    J Autoimmun; 2016 Jan; 66():108-17. PubMed ID: 26432598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis.
    Tanaka H; Yang GX; Iwakoshi N; Knechtle SJ; Kawata K; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Joh T; Bowlus C; Gershwin ME
    Clin Exp Immunol; 2013 Dec; 174(3):364-71. PubMed ID: 23981074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.